arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

OptimizeRx Corp

OPRX
$7.07 ▲ +0.33 (+4.90%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
16 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

OptimizeRx Corp shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap $131.2M
Dividend Yield
Revenue Growth 18.8%
Op. Margin 10.7%
ROIC 5.6%
FCF / Share $1.01
Trailing P/E 25.3x
Price / Book 1.0x
FCF Yield 14.2%
Debt / Equity 0.20
info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$109.43M
↑ +18.8%
Net Income Profit after all expenses
$5.13M
↑ +125.5%
Operating Margin Operating profit as % of sales
10.7%
↑ +171.8% 58th
FCF / Share Free cash flow per share
$1.01
↑ +285.0%
Long-Term Debt Long-term obligations
$26.29M
↓ -23.3%

Health Breakdown

Profitability
61
Returns
51
Financial Health
68
Cash Quality
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters